The scientific research of the School of Pharmaceutical Sciences (SPS) is mainly focused on three classes of diseases (cardiovascular and cerebrovascular diseases, tumor, and senile diseases), and fundamental research on four classes of endogenous substances (nucleic acids, oligosaccharides, polypeptides, and trace elements) as well as natural medicines. With the State Key Laboratory of Natural and Biomimetic Drugs as the core, and with the support from National Key Disciplines (Medicinal Chemistry, Pharmacognosy, and Pharmacology), SPS has built up a solid foundation in nucleic acid chemistry, peptide chemistry, carbohydrate chemistry, and bio-inorganic chemistry studies. Some disciplines and research achievements have reached international top level.

Currently, SPS undertakes a number of key research programs, including key projects from National Natural Science Foundation of China (NSFC), National Key Technologies R&D Programs of China. In the past five years, more than 900 SCI-cited articles were published on leading journals, including Science, Nature, Angew. Chem. Int. Ed., J. Am. Chem. Soc., Nucleic Acids Res., J. Control. Release, RNA, J. Med. Chem., and J. Nat. Prod. At the same time, SPS has obtained 90 issued patents. SPS will build up an integrated research and technology system for the discovery and development of innovative drugs, covering the whole technology chain from early discovery to later development of chemical drugs, Chinese medicine and natural medicine drugs, and biotechnological drugs. SPS intends to improve its innovation capability in new drug research, and to help China to change from “big” to “strong” in pharmaceutical industry.

The School of Pharmaceutical Sciences has extensive cooperation and communication with universities, research institutes, and pharmaceutical groups from US, UK, France, Germany, Japan, Netherland, Hong Kong, Macau, Taiwan, and so on. Widespread communications at home and abroad have been remarkably improving the school’s overall academic strength.